Heart failure & cardiomyopathies

Use of Heart Failure Medical Therapy Before and After a Cancer Diagnosis: A Longitudinal Study

ESC Heart FailPublished Longitudinal cohort study

Authors' conclusion

Following a cancer diagnosis, patients with HFrEF were more likely to have reduced use of GDMTs for HF.

Study context

Population
Patients with probable HF with reduced ejection fraction (HFrEF) in UK primary care records, 2005–20214,890 matched to controls
Participants
8,504 patients
Exposure
HFrEF patients with incident cancer vs matched HFrEF patients without cancer
Outcome
GDMT (renin-angiotensin-system inhibitors (RASIs), beta-blockers, mineralocorticoid receptor antagonists (MRAs)) adherence, persistence, initiation and dose titration
Follow-up
12 months after cancer diagnosis
Methodological details1:1 matched, UK Clinical Practice Research Datalink, 2005–2021
  • 1:1 matched
  • UK Clinical Practice Research Datalink, 2005–2021

Main finding

As reported in the abstract

Cancer vs Non-cancer controlsOdds ratio (95% CI)
Poor adherence, RASIs
1.51(1.35–1.68)
Poor adherence, beta-blockers
1.22(1.08–1.37)
Poor adherence, MRAs
1.31(1.08–1.59)
Poor persistence, RASIs
2.04(1.75–2.37)
Poor persistence, beta-blockers
1.35(1.12–1.63)
Poor persistence, MRAs
1.49(1.16–1.93)

Observational data: associations, not effects.

Further findings

OutcomeOR (95% CI)
Dose down-titrationCancervs Non-cancer controlsRASIs1.69 (1.40–2.04)
Dose down-titrationCancervs Non-cancer controlsBeta-blockers1.31 (1.05–1.62)

Treatment initiation and dose up-titration

Cancer diagnosis not associated with treatment initiation or dose up-titration

Heart failure (HF) hospitalisation and mortality by adherence/persistence

Higher event rates with poor adherence or persistence to guideline-directed medical therapies (GDMTs)

Original publication

Use of Heart Failure Medical Therapy Before and After a Cancer Diagnosis: A Longitudinal Study. ESC Heart Fail. Published 23 July 2024. doi:10.1002/ehf2.14981

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.